Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,17 USD | -8,59% | -4,10% | +35,26% |
Omzet 2024 * | 147 mln. 138 mln. | Omzet 2025 * | 165 mln. 155 mln. | Marktkapitalisatie | 136 mln. 128 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -146 mln. -137 mln. | Nettowinst (verlies) 2025 * | -182 mln. -171 mln. | EV/omzet 2024 * | 1,44 x |
Nettoschuld 2024 * | 74 mln. 69,47 mln. | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,83 x |
K/w-verhouding 2024 * |
-0,96
x | K/w-verhouding 2025 * |
-1,11
x | Werknemers | 325 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,01% |
Recentste transcriptie over Karyopharm Therapeutics Inc.
1 dag | -8,59% | ||
1 week | -4,10% | ||
Lopende maand | -22,52% | ||
1 maand | -14,60% | ||
3 maanden | +52,74% | ||
6 maanden | +10,38% | ||
Lopend jaar | +35,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 56 | 26-02-20 |
Mike Mason
DFI | Director of Finance/CFO | 49 | 25-02-19 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 03-10-13 |
Barry Greene
BRD | Director/Board Member | 60 | 01-01-13 |
Director/Board Member | 59 | 01-04-13 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.04% | 0 M€ | 0,00% | - | |
0.02% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 1,17 | -8,59% | 1 441 884 |
18-04-24 | 1,28 | -7,25% | 1 306 165 |
17-04-24 | 1,38 | +25,45% | 3 175 612 |
16-04-24 | 1,1 | -4,76% | 1 171 346 |
15-04-24 | 1,155 | -5,33% | 810 682 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,26% | 136 mln. | |
-3,10% | 102 mld. | |
+2,11% | 96,37 mld. | |
-1,80% | 21,37 mld. | |
-17,75% | 20,92 mld. | |
-6,91% | 18,64 mld. | |
-42,00% | 16,4 mld. | |
-28,19% | 13,53 mld. | |
+0,18% | 13,28 mld. | |
+19,90% | 10,85 mld. |